Treatment Registry
TR-0212 ActiveRecorded September 2026Last verified September 2026

Compounded tirzepatide

Sold by OrderlyMeds · Injection, vial · every compounded tirzepatide record

Recorded initial charges

First month

$299

first month, including required fees on record. The published monthly rate excludes one-time and annual fees; introductory and conditional rates may change. Some fee details are unverified or unpublished; this sum does not establish the full amount payable.

Medication · Monthly plan · recorded initial monthly payment$299

Added from the figures recorded below.

Price

TermPer monthCharged today
Monthly plan

“Compounded Tirzepatide GLP-1 injections $299”

Per month$299Charged today$299
2 month starter program

“Compounded Tirzepatide GLP-1/GIP injections $149/mo $299 for 2 months”

Per month$149Charged today$299
2 month special offer

“Compounded Tirzepatide GLP-1/GIP injections $224/mo $449 for 2 months”

Per month$224Charged today$449
Price sources
Visit OrderlyMeds

We earn nothing from this link. It opens OrderlyMeds's website without a paid referral.

History

  1. September 2026 — $299
  2. September 2026 — $299
  • September 2026 — Entry added to the register

Sourcing and terms

StatesAll 50 states
PrescriberAsynchronous review
CancellationWhen you sign up, you can cancel any time before the doctor finalizes your prescription, unless you've selected a multi-month plan. Our standard sign-up process includes month-to-month plans as well as multi-month options.
MembershipNone. “We have no membership fees or hidden costs-what you see is what you pay!”

Not yet checked: pharmacy and consult fee.

Recorded from orderlymeds.com. Unlike the price rows above, these carry a summary rather than a word-for-word quotation, so they are not shown in quotation marks.

Notes

  1. 1. September 2026 — Compounded product pages confirm shipments include 'your medication vial,' so compounded entries are recorded as injection-vial; brand pages explicitly say '(GLP-1 pen)' / '(GLP-1/GIP pen)' for Wegovy/Zepbound.

Treatment Registry is an independent editorial record. It is not a government registry, a licensing body, or a certification. An entry means we recorded what a company published on a given date. It does not mean we recommend the program, and it does not mean the program is approved by anyone.

This record

Entry
TR-0212
Medication category
compounded tirzepatide
Readings
2

Related records

Other records from OrderlyMeds

All OrderlyMeds programs and terms

Compounded tirzepatide at a similar price

The records either side of this one in the recorded spread. Not a ranking, and not a recommendation — a position among 374 records of the same molecule.

Cite this entry

Treatment Registry. (2026). OrderlyMeds — compounded tirzepatide (TR-0212). Last verified September 2026. Retrieved [your access date], from https://treatmentregistry.com/registry/TR-0212

Replace the bracket with the date you read it. Ours is the date we last checked the figures, which is a different thing and is given separately.